The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.
Open accessAbstract
The molecular and cellular mechanisms responsible for cytotoxic T lymphocyte (CTL)-induced immunopathology are not well defined. Using a model in which hepatitis B surface antigen (HBsAg)-specific CTL cause an acute necroinflammatory liver disease in HBsAg transgenic mice, we demonstrate that class I-restricted disease pathogenesis is an orderly, multistep process that involves direct as well as indirect consequences of CTL activation. It begins (step 1) almost immediately as a direct antigen-specific CTL-target cell interaction that triggers the HBsAg-positive hepatocyte to undergo programmed cell death (apoptosis). It progresses (step 2) within hours to a focal inflammatory response in which antigen-nonspecific lymphocytes and neutrophils amplify the local cytopathic effect of the CTL. The most destructive pathogenetic function of the CTL, however, is to secrete interferon gamma when they encounter antigen in vivo, thereby activating the intrahepatic macrophage and inducing a delayed-type hypersensitivity response (step 3) that destroys the liver and kills the mouse. We propose that the principles illustrated in this study are generally applicable to other models of class I-restricted, CTL-induced immunopathology, and we suggest that they contribute to the immunopathogenesis of viral hepatitis during hepatitis B virus infection in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication
Walker, C. M., Moody, D. J., Stites, D. P., & Levy, J. A. (1986) · Science · doi:10.1126/science.2431484 · Cited by 990
ACHAORBEA, H. (1988) · Cell · doi:10.1016/0092-8674(88)90558-2 · Cited by 925
γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites
Schofield, L., Villaquiran, J., Ferreira, A., Schellekens, H., Nussenzweig, R., & Nussenzweig, V. (1987) · Nature · doi:10.1038/330664a0 · Cited by 713
Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
Chisari, F. V., Klopchin, K., Moriyama, T., Pasquinelli, C., Dunsford, H. A., Sell, S., Pinkert, C. A., Brinster, R. L., & Palmiter, R. D. (1989) · Cell · doi:10.1016/0092-8674(89)90770-8 · Cited by 697
Self-citationBendelac, A., Carnaud, C., Boitard, C., & Bach, J. F. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.823 · Cited by 569
Buchmeier, N. A., & Schreiber, R. D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7404 · Cited by 542
Self-citationPace, J. L., Russell, S. W., Torres, B. A., Johnson, H. M., & Gray, P. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2011 · Cited by 442
Barth, R. J., Mulé, J. J., Spiess, P. J., & Rosenberg, S. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.647 · Cited by 402
Sheehan, K. C. F., Ruddle, N. H., & Schreiber, R. D. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.11.3884 · Cited by 379
Self-citationImmunobiology and Pathogenesis of Hepatocellular Injury in Hepatitis B Virus Transgenic Mice
Moriyama, T., Guilhot, S., Klopchin, K., Moss, B., Pinkert, C. A., Palmiter, R. D., Brinster, R. L., Kanagawa, O., & Chisari, F. V. (1990) · Science · doi:10.1126/science.1691527 · Cited by 366
Self-citation
Cited by
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R., & Chisari, F. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80295-2 · Cited by 1,083
Self-citationIMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Self-citationMaini, M. K., Boni, C., Lee, C. K., Larrubia, J. R., Reignat, S., Ogg, G. S., King, A. S., Herberg, J., Gilson, R., Alisa, A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1269 · Cited by 800
Alexander, W. S., Starr, R., Fenner, J. E., Scott, C. L., Handman, E., Sprigg, N. S., Corbin, J. E., Cornish, A. L., Darwiche, R., Owczarek, C. M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80047-1 · Cited by 762
Hepatic T cells and liver tolerance
Crispe, I. N. (2003) · Nature Reviews Immunology · doi:10.1038/nri981 · Cited by 661
Yang, Y., Ertl, H. C. J., & Wilson, J. M. (1994) · Immunity · doi:10.1016/1074-7613(94)90074-4 · Cited by 611
Bertoletti, A., Sette, A., Chisari, F. V., Penna, A., Levrero, M., Carli, M. D., Fiaccadori, F., & Ferrari, C. (1994) · Nature · doi:10.1038/369407a0 · Cited by 540
Self-citationSuda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 508
Adaptive immunity in HBV infection
Bertoletti, A., & Ferrari, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.026 · Cited by 483
Essential roles of the Fas ligand in the development of hepatitis
Kondo, T., Suda, T., Fukuyama, H., Adachi, M., & Nagata, S. (1997) · Nature Medicine · doi:10.1038/nm0497-409 · Cited by 479
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Rehermann, B. (2013) · Nature Medicine · doi:10.1038/nm.3251 · Cited by 468
Dunn, C., Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., Das, A., Lopes, A. R., Borrow, P., Williams, K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061287 · Cited by 421
Tsai, S., Liaw, Y., Chen, M., Huang, C., & Kuo, G. C. (1997) · Hepatology · doi:10.1002/hep.510250233 · Cited by 415
Incubation Phase of Acute Hepatitis B in Man: Dynamic of Cellular Immune Mechanisms
Webster, G. J. M., Reignat, S., Maini, M. K., Whalley, S. A., Ogg, G. S., King, A., Brown, D., Amlot, P. L., Williams, R., Vergani, D., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.19324 · Cited by 414
Guidotti, L. G., Ando, K., Hobbs, M. V., Ishikawa, T., Runkel, L., Schreiber, R. D., & Chisari, F. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3764 · Cited by 412
Self-citationTargeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver
Adachi, M., Suematsu, S., Kondo, T., Ogasawara, J., Tanaka, T., Yoshida, N., & Nagata, S. (1995) · Nature Genetics · doi:10.1038/ng1195-294 · Cited by 374
Immune Pathogenesis of Hepatocellular Carcinoma
Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P., & Chisari, F. V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.341 · Cited by 373
Self-citationBcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice
Lacronique, V., Mignon, A., Fabre, M., Viollet, B., Rouquet, N., Molina, T., Porteu, A., Henrion, A., Bouscary, D., Varlet, P., et al. (1996) · Nature Medicine · doi:10.1038/nm0196-80 · Cited by 369
Cytotoxic T cells and viral hepatitis.
Chisari, F. V. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119308 · Cited by 367
Self-citationFas and Fas Ligand: A Death Factor and Its Receptor
Nagata, S. (1994) · Advances in Immunology · doi:10.1016/s0065-2776(08)60672-0 · Cited by 338
Differential Cd4+ and Cd8+ T–Cell Responsiveness in Hepatitis C Virus Infection
Chang, K.-M., Thimme, R., Melpolder, J. J., Oldach, D., Pemberton, J., Moorhead-Loudis, J., McHutchison, J. G., Alter, H. J., & Chisari, F. V. (2001) · Hepatology · doi:10.1053/jhep.2001.21162 · Cited by 336
Self-citationThe role of cytokines in hepatocellular carcinoma
Budhu, A., & Wang, X. W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0506297 · Cited by 319
Koziel, M. J., Dudley, D., Afdhal, N., Grakoui, A., Rice, C. M., Choo, Q. L., Houghton, M., & Walker, B. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118287 · Cited by 315
Antitumor effect of locally produced CD95 ligand
Seino, K.-I., Kayagaki, N., Okumura, K., & Yagita, H. (1997) · Nature Medicine · doi:10.1038/nm0297-165 · Cited by 312
Viruses, Immunity, and Cancer: Lessons from Hepatitis B
Chisari, F. V. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64980-2 · Cited by 304
Self-citationImportance of Kupffer Cells for T-Cell-Dependent Liver Injury in Mice
Schümann, J., Wolf, D., Pahl, A., Brune, K., Papadopoulos, T., van Rooijen, N., & Tiegs, G. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64804-3 · Cited by 284
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications
Pollicino, T., Cacciola, I., Saffioti, F., & Raimondo, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.041 · Cited by 277
Acute liver failure: mechanisms of immune-mediated liver injury
Wu, Z., Han, M., Chen, T., Yan, W., & Ning, Q. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02262.x · Cited by 274
HBV-Induced Immune Imbalance in the Development of HCC
Chen, Y., & Tian, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02048 · Cited by 270
Apoptosis and hepatobiliary disease
Patel, T., & Gores, G. J. (1995) · Hepatology · doi:10.1002/hep.1840210635 · Cited by 264
Yang, Y., Xiang, Z., Ertl, H. C., & Wilson, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7257 · Cited by 260
Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection
Das, A., Hoare, M., Davies, N., Lopes, A. R., Dunn, C., Kennedy, P. T. F., Alexander, G., Finney, H., Lawson, A., Plunkett, F. J., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072076 · Cited by 256
McClary, H., Koch, R., Chisari, F. V., & Guidotti, L. G. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2255-2264.2000 · Cited by 255
Self-citationNaturally Occurring Variants of Hepatitis B Virus
Günther, S., Fischer, L., Pult, I., Sterneck, M., & Will, H. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60298-5 · Cited by 255
Kakimi, K., Lane, T. E., Wieland, S., Asensio, V. C., Campbell, I. L., Chisari, F. V., & Guidotti, L. G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1755 · Cited by 234
Self-citationOscillating CD8+ T Cell Effector Functions after Antigen Recognition in the Liver
Isogawa, M., Furuichi, Y., & Chisari, F. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.005 · Cited by 186
Self-citationCharles, P. C., Trgovcich, J., Davis, N. L., & Johnston, R. E. (2001) · Virology · doi:10.1006/viro.2001.0878 · Cited by 79
Metadata
- Authors
- Ando, K., Moriyama, T., Guidotti, L. G., Wirth, S., Schreiber, R. D., Schlicht, H. J., Huang, S. N., & Chisari, F. V.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-11-01
- Volume
- 178
- Issue
- 5
- Pages
- 1541-1554
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2054968862
- Cited by
- 449
- References
- 39
- FWCI
- 20.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.